{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:50Z","timestamp":1786985270024,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118009","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T14:52:45Z","timestamp":1743346365000},"page":"118009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative analysis of micellar and native formulations of Boswellia serrata oleogum extracts in T-cell receptor-activated lymphocytes"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4219-3911","authenticated-orcid":false,"given":"Amira","family":"Duweb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schmiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emaad","family":"Abdel-Kahaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna","family":"El Gaafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Simmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Syrovets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118009_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14280","article-title":"Inflammation unites diverse acute and chronic diseases","author":"Libby","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biopha.2025.118009_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118009_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636720","article-title":"Single cell analysis of blood mononuclear cells stimulated through either LPS or anti-CD3 and anti-CD28","volume":"12","author":"Lawlor","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-a: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2010.05825.x","article-title":"The IL-17 pathway as a major therapeutic target in autoimmune diseases","volume":"1217","author":"Hu","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118009_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118009_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd2196","article-title":"Biologic therapies in rheumatology: lessons learned, future directions","volume":"6","author":"Strand","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118009_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nchembio0707-360","article-title":"Revisiting the ancient concept of botanical therapeutics","volume":"3","author":"Schmidt","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2025.118009_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-3-319-41334-1_13","article-title":"Boswellic acids and their role in chronic inflammatory diseases","volume":"928","author":"Ammon","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2025.118009_bib10","first-page":"321","article-title":"A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis","volume":"7","author":"Togni","year":"2014","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.biopha.2025.118009_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ph14050437","article-title":"Considerations to be taken when carrying out medicinal plant research-what we learn from an insight into the IC50 values, bioavailability and clinical efficacy of exemplary anti-inflammatory herbal components","volume":"14","author":"Abdel-Tawab","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118009_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.174.1.498","article-title":"Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-a induction in monocytes by direct interaction with IkappaB kinases","volume":"174","author":"Syrovets","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/ATVBAHA.107.155606","article-title":"Antiinflammatory and antiatherogenic effects of the NF-kB inhibitor acetyl-11-keto-b-boswellic acid in LPS-challenged ApoE-\/- mice","volume":"28","author":"Cuaz-P\u00e9rolin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2025.118009_bib14","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.4049\/jimmunol.0900521","article-title":"Targeting NF-kB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis","volume":"183","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102341","article-title":"Comparative investigation of frankincense nutraceuticals: correlation of boswellic and lupeolic acid contents with cytokine release inhibition and toxicity against triple-negative breast cancer cells","volume":"11","author":"Schmiech","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118009_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.intimp.2006.12.003","article-title":"Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFa, IL-1b, NO and MAP kinases","volume":"7","author":"Gayathri","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118009_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104694","article-title":"Boswellia carteri extract and 3-O-acetyl-a-boswellic acid suppress T cell function","volume":"146","author":"Zimmermann-Klemd","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2025.118009_bib18","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1055\/s-2004-835844","article-title":"Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers","volume":"70","author":"Sterk","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2025.118009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nfs.2018.04.001","article-title":"Enhanced absorption of boswellic acids by a micellar solubilized delivery form of Boswellia extract","author":"Meins","year":"2018","journal-title":"NFS J."},{"key":"10.1016\/j.biopha.2025.118009_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155863","article-title":"Single-dose comparative pharmacokinetic\/pharmacodynamic study of a micellar formulation versus a native Boswellia serrata dry extract in healthy volunteers","volume":"132","author":"Schmiech","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118009_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/JLB.1A1221-680R","article-title":"The SC cell line as an in vitro model of human monocytes","volume":"112","author":"Duweb","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2025.118009_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","article-title":"Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-\u03baB, NFAT and AP-1","volume":"430","author":"Jutz","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2025.118009_bib23","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.1602033","article-title":"Integration of kinase and calcium signaling at the level of chromatin underlies inducible gene activation in T cells","volume":"199","author":"Brignall","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/imr.12796","article-title":"mTOR and other effector kinase signals that impact T cell function and activity","volume":"291","author":"Myers","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2025.118009_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar2338","article-title":"Activator protein 1 (Fos\/Jun) functions in inflammatory bone and skin disease","volume":"10","author":"Zenz","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2025.118009_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI11891","article-title":"Series introduction: the transcription factor NF-kB and human disease","volume":"107","author":"Baldwin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2025.118009_bib27","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.157.12.5277","article-title":"Activation of Nuclear Factor-kB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin","volume":"157","author":"Kanno","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib28","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2025.118009_bib29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.phymed.2016.07.009","article-title":"A single-dose, randomized, cross-over, two-way, open-label study for comparing the absorption of boswellic acids and its lecithin formulation","volume":"23","author":"Riva","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118009_bib30","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/eji.1830260726","article-title":"Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression","volume":"26","author":"Meisel","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon gamma: a master regulator of atherosclerosis","volume":"20","author":"McLaren","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2025.118009_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2008.00697.x","article-title":"Interleukin-2 in the development and control of inflammatory disease","volume":"226","author":"Hoyer","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2025.118009_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134174","article-title":"Effects of frankincense compounds on infection, inflammation, and oral health","volume":"27","author":"Almeida-da-Silva","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118009_bib34","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1111\/jocd.15206","article-title":"Evaluation of antibacterial and wound-healing activities of alcoholic extract of Boswellia carterii, in vitro and in vivo study","volume":"21","author":"Hasson","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.biopha.2025.118009_bib35","doi-asserted-by":"crossref","first-page":"26396","DOI":"10.1016\/S0021-9258(18)47207-9","article-title":"Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase","volume":"269","author":"Westwick","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118009_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118009_bib37","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1002\/jps.21190","article-title":"Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways","volume":"97","author":"Kerwin","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118009_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-2272-7_3","article-title":"Getting across the cell membrane: an overview for small molecules, peptides, and proteins","volume":"1266","author":"Yang","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118009_bib39","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.xphs.2017.03.001","article-title":"Trends on analytical characterization of polysorbates and their degradation products in biopharmaceutical formulations","volume":"106","author":"Martos","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118009_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105036","article-title":"Role of stealth lipids in nanomedicine-based drug carriers","volume":"235","author":"Rastogi","year":"2021","journal-title":"Chem. Phys. Lipids"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:59:12Z","timestamp":1781823552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"alternative-id":["S0753332225002033"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118009","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of micellar and native formulations of Boswellia serrata oleogum extracts in T-cell receptor-activated lymphocytes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118009"}}